UPDATE 1-Pfizer's Xeljanz gets FDA nod as joint disease treatment
December 14, 2017 at 20:13 PM EST
Dec 14 (Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint disease.
